These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. The challenge to provide affordable rabies post-exposure treatment. Meslin FX Vaccine; 2003 Oct; 21(27-30):4122-3. PubMed ID: 14505890 [No Abstract] [Full Text] [Related]
7. Simulated post-exposure rabies vaccination: comments on article by Madhusudana et al. Wilde H; Khawplod P; Hemachudha T Int J Infect Dis; 2004 Nov; 8(6):374-5; author reply 376. PubMed ID: 15494259 [No Abstract] [Full Text] [Related]
8. Three-year experience with 4-site intradermal booster vaccination with rabies vaccine for postexposure prophylaxis. Tantawichien T; Tantawichien T; Supit C; Khawplod P; Sitprija V Clin Infect Dis; 2001 Dec; 33(12):2085-7. PubMed ID: 11712097 [TBL] [Abstract][Full Text] [Related]
9. Intradermal regimens for rabies postexposure prophylaxis: more confusion. Warrell MJ; Warrell DA Clin Infect Dis; 2002 Jul; 35(2):213-5; author reply 215. PubMed ID: 12087534 [No Abstract] [Full Text] [Related]
10. Intradermal immunization for rabies prophylaxis: issues to be considered in India and other developing countries. Madhusudana SN Vaccine; 2003 Jul; 21(23):3095-6. PubMed ID: 12804834 [No Abstract] [Full Text] [Related]
11. The effectiveness of small dose intradermal rabies vaccine. Ramadas D; Black K; Sathasivam A J Trop Pediatr; 1990 Dec; 36(6):276-8. PubMed ID: 2280432 [No Abstract] [Full Text] [Related]
12. Preventing rabies with the Verorab vaccine: 1985-2005 Twenty years of clinical experience. Toovey S Travel Med Infect Dis; 2007 Nov; 5(6):327-48. PubMed ID: 17983973 [TBL] [Abstract][Full Text] [Related]
13. Failure of multiple-site intradermal postexposure rabies vaccination in patients with human immunodeficiency virus with low CD4+ T lymphocyte counts. Tantawichien T; Jaijaroensup W; Khawplod P; Sitprija V Clin Infect Dis; 2001 Nov; 33(10):E122-4. PubMed ID: 11641838 [TBL] [Abstract][Full Text] [Related]
14. Prospective immunogenicity study of multiple intradermal injections of rabies vaccine in an effort to obtain an early immune response without the use of immunoglobulin. Khawplod P; Wilde H; Tepsumethanon S; Limusanno S; Tantawichien T; Chomchey P; Ayuthaya AB; Wangroonsarb Y Clin Infect Dis; 2002 Dec; 35(12):1562-5. PubMed ID: 12471579 [TBL] [Abstract][Full Text] [Related]
15. Revision of the Thai Red Cross intradermal rabies post-exposure regimen by eliminating the 90-day booster injection. Khawplod P; Wilde H; Sirikwin S; Benjawongkulchai M; Limusanno S; Jaijaroensab W; Chiraguna N; Supich C; Wangroongsarb Y; Sitprija V Vaccine; 2006 Apr; 24(16):3084-6. PubMed ID: 16494972 [TBL] [Abstract][Full Text] [Related]
16. Current therapies in rabies. Hendekli CM Arch Virol; 2005 Jun; 150(6):1047-57. PubMed ID: 15747048 [No Abstract] [Full Text] [Related]